The tumor microenvironment and metastatic disease

Clinical and Experimental Metastasis

Volumn 26, Issue 1, 2009, Pages 19-34

  Lunt, Sarah Jane ^a,b   Chaudary, Naz ^a,b   Hill, Richard P ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Extracellular matrix; Gene expression; Heterogeneity; Hypoxia; Interstitial fluid pressure; Metastasis; Tumor microenvironment

Indexed keywords

ARTICLE; CANCER GENETICS; CELL INTERACTION; EPIGENETICS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HYPOXIA; METASTASIS; MICROENVIRONMENT; NONHUMAN; PATHOPHYSIOLOGY; PH; TISSUE PRESSURE;

CELL HYPOXIA; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 58949092790     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-008-9182-2     Document Type: Article

References (215)

1. R Sullivan CH Graham 2007 Hypoxia-driven selection of the metastatic phenotype Cancer Metastasis Rev 26 2 319 331 10.1007/s10555-007-9062-2
2. DA Chan AJ Giaccia 2007 Hypoxia, gene expression, and metastasis Cancer Metastasis Rev 26 2 333 339 10.1007/s10555-007-9063-1
3. RA Cairns R Khokha RP Hill 2003 Molecular mechanisms of tumor invasion and metastasis: an integrated view Curr Mol Med 3 7 659 671 10.2174/ 1566524033479447
4. EK Rofstad 2000 Microenvironment-induced cancer metastasis Int J Radiat Biol 76 5 589 605 10.1080/095530000138259
5. P Subarsky RP Hill 2003 The hypoxic tumour microenvironment and metastatic progression Clin Exp Metastasis 20 3 237 250 10.1023/A:1022939318102
6. P Vaupel 2004 The role of hypoxia-induced factors in tumor progression Oncologist 9 Suppl 5 10 17 10.1634/theoncologist.9-90005-10
7. M Milosevic A Fyles D Hedley 2004 The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure Semin Radiat Oncol 14 3 249 258 10.1016/j.semradonc.2004.04.006
8. M Nordsmark JG Eriksen V Gebski 2007 Differential risk assessments from five hypoxia specific assays: the basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients Radiother Oncol 83 3 389 397 10.1016/j.radonc.2007.04.021
9. M Hockel K Schlenger B Aral 1996 Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 19 4509 4515
10. A Fyles M Milosevic D Hedley 2002 Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer J Clin Oncol 20 3 680 687 10.1200/JCO.20.3.680
11. DM Brizel SP Scully JM Harrelson 1996 Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 5 941 943
12. RA Cairns T Kalliomaki RP Hill 2001 Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors Cancer Res 61 24 8903 8908
13. RA Cairns RP Hill 2004 Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma Cancer Res 64 6 2054 2061 10.1158/0008-5472.CAN-03-3196
14. TG Graeber C Osmanian T Jacks 1996 Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 6560 88 91 10.1038/379088a0
15. JT Erler KL Bennewith M Nicolau 2006 Lysyl oxidase is essential for hypoxia-induced metastasis Nature 440 7088 1222 1226 10.1038/nature04695
16. B Krishnamachary S Berg-Dixon B Kelly 2003 Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1 Cancer Res 63 5 1138 1143
17. DM Brizel T Schroeder RL Scher 2001 Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2 349 353 10.1016/S0360-3016(01)01630-3
18. Weidner N (1998) Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184(2):119-122. doi:10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D
19. K Sundfor H Lyng EK Rofstad 1998 Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix Br J Cancer 78 6 822 827
20. CM West RA Cooper JA Loncaster 2001 Tumor vascularity: a histological measure of angiogenesis and hypoxia Cancer Res 61 7 2907 2910
21. SD Young RS Marshall RP Hill 1988 Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells Proc Natl Acad Sci USA 85 24 9533 9537 10.1073/pnas.85.24.9533
22. CW Stackpole L Groszek SS Kalbag 1994 Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia J Natl Cancer Inst 86 5 361 367 10.1093/jnci/86.5.361
23. EK Rofstad T Danielsen 1999 Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis Br J Cancer 80 11 1697 1707 10.1038/sj.bjc.6690586
24. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10.1016/S0092-8674(00)81683-9
25. Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80(8 Suppl):1529-1537. doi:10.1002/(SICI)1097-0142(19971015) 80:8+<1529::AID-CNCR2>3.0.CO;2-F
26. CO McDonnell AD Hill DA McNamara 2000 Tumour micrometastases: the influence of angiogenesis Eur J Surg Oncol 26 2 105 115 10.1053/ejso.1999.0753
27. P Baluk S Morikawa A Haskell 2003 Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors Am J Pathol 163 5 1801 1815
28. F Kallinowski G Tyler W Mueller-Klieser 1989 Growth-related changes of oxygen consumption rates of tumor cells grown in vitro and in vivo J Cell Physiol 138 1 183 191 10.1002/jcp.1041380124
29. P Vaupel F Kallinowski P Okunieff 1989 Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 6449 6465
30. RH Thomlinson LH Gray 1955 The histological structure of some human lung cancers and the possible implications for radiotherapy Br J Cancer 9 4 539 549
31. AJ Franko RM Sutherland 1978 Rate of death of hypoxic cells in multicell spheroids Radiat Res 76 3 561 572 10.2307/3574805
32. RE Durand JA Raleigh 1998 Identification of nonproliferating but viable hypoxic tumor cells in vivo Cancer Res 58 16 3547 3550
33. JM Brown 1979 Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism for reoxygenation Br J Radiol 52 650 656
34. RM Sutherland AJ Franko 1980 On the nature of the radiobiologically hypoxic fraction in tumors Int J Radiat Oncol Biol Phys 6 1 117 120
35. KL Bennewith RE Durand 2004 Quantifying transient hypoxia in human tumor xenografts by flow cytometry Cancer Res 64 17 6183 6189 10.1158/0008-5472.CAN- 04-0289
36. J Lanzen RD Braun B Klitzman 2006 Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor Cancer Res 66 4 2219 2223 10.1158/0008-5472.CAN-03-2958
37. KG Brurberg M Thuen EB Ruud 2006 Fluctuations in pO2 in irradiated human melanoma xenografts Radiat Res 165 1 16 25 10.1667/RR3491.1
38. L Holmquist A Jogi S Pahlman 2005 Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells Int J Cancer 116 2 218 225 10.1002/ijc.21024
39. P Subarsky RP Hill 2008 Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells Clin Exp Metastasis 25 3 253 264
40. L Zhang RP Hill 2004 Hypoxia enhances metastatic efficiency by up-regulating Mdm2 in KHT cells and increasing resistance to apoptosis Cancer Res 64 12 4180 4189 10.1158/0008-5472.CAN-03-3038
41. L Zhang RP Hill 2007 Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion Cancer Res 67 16 7789 7797 10.1158/0008-5472.CAN-06-4221
42. J Folkman 1974 Tumor angiogenesis Adv Cancer Res 19 331 358 10.1016/S0065-230X(08)60058-5
43. HF Dvorak JA Nagy D Feng 1999 Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis Curr Top Microbiol Immunol 237 97 132
44. GL Semenza 2001 Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol Med 7 8 345 350 10.1016/S1471-4914(01)02090-1
45. Semenza GL (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; (407): cm8
46. GL Semenza 2003 Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 10 721 732 10.1038/nrc1187
47. J Zhou T Schmid S Schnitzer 2006 Tumor hypoxia and cancer progression Cancer Lett 237 1 10 21 10.1016/j.canlet.2005.05.028
48. K Hirota GL Semenza 2006 Regulation of angiogenesis by hypoxia-inducible factor 1 Crit Rev Oncol Hematol 59 1 15 26 10.1016/j.critrevonc.2005.12.003
49. NJ Mabjeesh S Amir 2007 Hypoxia-inducible factor (HIF) in human tumorigenesis Histol Histopathol 22 5 559 572
50. GL Semenza MK Nejfelt SM Chi 1991 Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene Proc Natl Acad Sci USA 88 13 5680 5684 10.1073/pnas.88.13.5680
51. JI Bardos M Ashcroft 2005 Negative and positive regulation of HIF-1: a complex network Biochim Biophys Acta 1755 2 107 120
52. GL Wang GL Semenza 1993 General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia Proc Natl Acad Sci USA 90 9 4304 4308 10.1073/pnas.90.9.4304
53. M Gruber MC Simon 2006 Hypoxia-inducible factors, hypoxia, and tumor angiogenesis Curr Opin Hematol 13 3 169 174 10.1097/01.moh.0000219663.88409.35
54. C Brahimi-Horn J Pouyssegur 2006 The role of the hypoxia-inducible factor in tumor metabolism growth and invasion Bull Cancer 93 8 E73 E80
55. Y Mizukami Y Kohgo DC Chung 2007 Hypoxia inducible factor-1 independent pathways in tumor angiogenesis Clin Cancer Res 13 19 5670 5674 10.1158/1078-0432.CCR-07-0111
56. PH Maxwell GU Dachs JM Gleadle 1997 Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Proc Natl Acad Sci USA 94 15 8104 8109 10.1073/pnas.94.15.8104
57. J Aragones M Schneider K Van Geyte 2008 Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism Nat Genet 40 2 170 180 10.1038/ng.2007.62
58. ML Coleman PJ Ratcliffe 2007 Oxygen sensing and hypoxia-induced responses Essays Biochem 43 1 15 10.1042/BSE0430001
59. MA Maynard M Ohh 2007 The role of hypoxia-inducible factors in cancer Cell Mol Life Sci 64 16 2170 2180 10.1007/s00018-007-7082-2
60. S Rocha 2007 Gene regulation under low oxygen: holding your breath for transcription Trends Biochem Sci 32 8 389 397 10.1016/j.tibs.2007.06.005
61. YL Liu JM Yu XR Song 2006 Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines Cancer Biol Ther 5 10 1320 1326
62. RR Raval KW Lau MG Tran 2005 Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma Mol Cell Biol 25 13 5675 5686 10.1128/MCB.25.13.5675-5686.2005
63. SC Winter KA Shah C Han 2006 The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer Cancer 107 4 757 766 10.1002/cncr.21983
64. MA Maynard H Qi J Chung 2003 Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex J Biol Chem 278 13 11032 11040 10.1074/jbc.M208681200
65. YZ Gu SM Moran JB Hogenesch 1998 Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha Gene Expr 7 3 205 213
66. Y Makino R Cao K Svensson 2001 Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression Nature 414 6863 550 554 10.1038/35107085
67. E Berra E Benizri A Ginouves 2003 HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia EMBO J 22 16 4082 4090 10.1093/emboj/cdg392
68. RJ Appelhoff YM Tian RR Raval 2004 Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor J Biol Chem 279 37 38458 38465 10.1074/jbc.M406026200
69. KS Hewitson CJ Schofield PJ Ratcliffe 2007 Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2 Meth Enzymol 435 25 42 10.1016/S0076-6879(07)35002-7
70. G D'Angelo E Duplan N Boyer 2003 Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation J Biol Chem 278 40 38183 38187 10.1074/jbc.M302244200
71. N Erez M Milyavsky R Eilam 2003 Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth Cancer Res 63 24 8777 8783
72. BJ Moeller Y Cao Z Vujaskovic 2003 Reactive oxygen species and hypoxia inducible factor-1alpha serve as important vascular stabilizing elements in tumors following radiotherapy Int J Radiat Oncol Biol Phys 57 2 Suppl S320 S321 10.1016/S0360-3016(03)01198-2
73. GL Semenza NR Prabhakar 2007 HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia Antioxid Redox Signal 9 9 1391 1396 10.1089/ars.2007.1691
74. DC Radisky 2005 Epithelial-mesenchymal transition J Cell Sci 118 4325 4326 10.1242/jcs.02552
75. N Bonitsis A Batistatou S Karantima 2006 The role of cadherin/catenin complex in malignant melanoma Exp Oncol 28 3 187 193
76. M Bienz 2005 beta-Catenin: a pivot between cell adhesion and Wnt signalling Curr Biol 15 2 R64 R67 10.1016/j.cub.2004.12.058
77. B Hotz M Arndt S Dullat 2007 Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer Clin Cancer Res 13 16 4769 4776 10.1158/1078-0432.CCR-06-2926
78. T Imai A Horiuchi C Wang 2003 Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells Am J Pathol 163 4 1437 1447
79. S Kokura N Yoshida E Imamoto 2004 Anoxia/reoxygenation down-regulates the expression of E-cadherin in human colon cancer cell lines Cancer Lett 211 1 79 87 10.1016/j.canlet.2004.01.030
80. Tanimoto K, Yoshiga K, Eguchi H, et al (2003) Hypoxia-inducible factor-1{alpha} polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24(11):1779-1783
81. NK Kurrey K A SA Bapat 2005 Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level Gynecol Oncol 97 1 155 165 10.1016/j.ygyno.2004.12.043
82. NE Davidson S Sukumar 2005 Of Snail, mice, and women Cancer Cell 8 3 173 174 10.1016/j.ccr.2005.08.006
83. Q Chang R Qin T Huang 2006 Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer Pancreas 32 3 297 305 10.1097/00006676-200604000-00010
84. S Arao A Masumoto M Otsuki 2000 Beta1 integrins play an essential role in adhesion and invasion of pancreatic carcinoma cells Pancreas 20 2 129 137 10.1097/00006676-200003000-00004
85. PA Andreasen R Egelund HH Petersen 2000 The plasminogen activation system in tumor growth, invasion, and metastasis Cell Mol Life Sci 57 1 25 40 10.1007/s000180050497
86. C Festuccia V Dolo F Guerra 1998 Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells Clin Exp Metastasis 16 6 513 528 10.1023/A:1006590217724
87. Graham CH, Forsdike J, Fitzgerald CJ et al (1999) Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80(4):617-623. doi:10.1002/(SICI) 1097-0215(19990209) 80:4<617::AID-IJC22>3.0.CO;2-C
88. SP Osinsky II Ganusevich LN Bubnovskaya 2005 Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis Exp Oncol 27 3 202 205
89. EK Rofstad H Rasmussen K Galappathi 2002 Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor Cancer Res 62 6 1847 1853
90. MT Canning LM Postovit SH Clarke 2001 Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells Exp Cell Res 267 1 88 94 10.1006/excr.2001.5243
91. B Sun D Zhang S Zhang 2007 Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma Cancer Lett 249 2 188 197 10.1016/j.canlet.2006.08.016
92. S Pennacchietti P Michieli M Galluzzo 2003 Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 4 347 361 10.1016/S1535-6108(03)00085-0
93. S Corso C Migilore E Ghiso 2008 Silencing the MET oncogene leads to regression of experimental tumors and metastases Oncogene 27 5 684 693
94. MZ Ratajczak E Zuba-Surma M Kucia 2006 The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis Leukemia 20 11 1915 1924 10.1038/sj.leu.2404357
95. A Ben-Baruch 2008 Organ selectivity in metastasis: regulation by chemokines and their receptors Clin Exp Metastasis 25 4 345 356
96. T Nagasawa 2000 A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis Int J Hematol 72 4 408 411
97. A Muller B Homey H Soto 2001 Involvement of chemokine receptors in breast cancer metastasis Nature 410 6824 50 56 10.1038/35065016
98. T Engl B Relja C Blumenberg 2006 Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix Life Sci 78 16 1784 1793 10.1016/j.lfs.2005.08.019
99. Engl T, Relja B, Marian D et al (2006) CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia (New York, N.Y.) 8(4):290-301. 10.1593/neo.05694
100. CC Schimanski R Bahre I Gockel 2006 Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4 Br J Cancer 95 2 210 217 10.1038/sj.bjc.6603251
101. CC Wykoff CW Pugh AL Harris 2001 The HIF pathway: implications for patterns of gene expression in cancer Novartis Found Symp 240 212 225 discussion 25-31
102. J Pan J Mestas MD Burdick 2006 Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis Mol Cancer 5 56 10.1186/1476-4598-5-56
103. JT Erler AJ Giaccia 2006 Lysyl oxidase mediates hypoxic control of metastasis Cancer Res 66 21 10238 10241 10.1158/0008-5472.CAN-06-3197
104. NC Denko LA Fontana KM Hudson 2003 Investigating hypoxic tumor physiology through gene expression patterns Oncogene 22 37 5907 5914 10.1038/sj.onc. 1206703
105. H Abedi I Zachary 1997 Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells J Biol Chem 272 24 15442 15451 10.1074/jbc.272.24.15442
106. JS Isaacs YJ Jung EG Mimnaugh 2002 Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway J Biol Chem 277 33 29936 29944 10.1074/jbc.M204733200
107. S Rousseau F Houle H Kotanides 2000 Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase J Biol Chem 275 14 10661 10672 10.1074/jbc.275.14.10661
108. PM Siesser SK Hanks 2006 The signaling and biological implications of FAK overexpression in cancer Clin Cancer Res 12 111 3233 3237 10.1158/1078-0432. CCR-06-0456
109. Y Zhu DT Denhardt H Cao 2005 Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer Oncogene 24 43 6555 6563
110. PY Wai PC Kuo 2004 The role of Osteopontin in tumor metastasis J Surg Res 121 2 228 241 10.1016/j.jss.2004.03.028
111. AB Tuck DM Arsenault FP O'Malley 1999 Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells Oncogene 18 29 4237 4246 10.1038/sj.onc.1202799
112. AB Tuck FP O'Malley H Singhal 1997 Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas Arch Pathol Lab Med 121 6 578 584
113. Tuck AB, O'Malley FP, Singhal H et al (1998) Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 79(5):502-508. doi:10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3
114. GN Thalmann RA Sikes RE Devoll 1999 Osteopontin: possible role in prostate cancer progression Clin Cancer Res 5 8 2271 2277
115. D Agrawal T Chen R Irby 2002 Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 7 513 521
116. TJ Yeatman AF Chambers 2003 Osteopontin and colon cancer progression Clin Exp Metastasis 20 1 85 90 10.1023/A:1022502805474
117. QT Le PD Sutphin S Raychaudhuri 2003 Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Clin Cancer Res 9 1 59 67
118. J Overgaard JG Eriksen M Nordsmark 2005 Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial Lancet Oncol 6 10 757 764 10.1016/S1470-2045(05)70292-8
119. VH Bramwell AB Tuck SM Wilson 2005 Expression of osteopontin and HGF/met in adult soft tissue tumors Cancer Biol Ther 4 12 1336 1341
120. DR Senger SJ Galli AM Dvorak 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 4587 983 985 10.1126/science.6823562
121. D Shweiki A Itin D Soffer 1992 Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 6398 843 845 10.1038/359843a0
122. JA Forsythe BH Jiang NV Iyer 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol Cell Biol 16 9 4604 4613
123. Y Mizukami J Li X Zhang 2004 Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer Cancer Res 64 5 1765 1772 10.1158/0008-5472.CAN-03-3017
124. T Veikkola M Karkkainen L Claesson-Welsh 2000 Regulation of angiogenesis via vascular endothelial growth factor receptors Cancer Res 60 2 203 212
125. EK Rofstad T Danielsen 1998 Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma Br J Cancer 77 6 897 902
126. CC Solorzano CH Baker CJ Bruns 2001 Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases Cancer Biother Radiopharm 16 5 359 370 10.1089/108497801753354267
127. H Kanayama S Yano SJ Kim 1999 Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice Clin Exp Metastasis 17 10 831 840 10.1023/A:1006792007063
128. A Jang RP Hill 1997 An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells Clin Exp Metastasis 15 5 469 483 10.1023/A:1018470709523
129. C Murdoch A Giannoudis CE Lewis 2004 Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues Blood 104 8 2224 2234 10.1182/blood-2004-03-1109
130. HJ Knowles AL Harris 2007 Macrophages and the hypoxic tumour microenvironment Front Biosci 12 4298 4314 10.2741/2389
131. I Desbaillets AC Diserens N Tribolet 1997 Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis J Exp Med 186 8 1201 1212 10.1084/jem.186.8.1201
132. A Yoshida S Yoshida AK Khalil 1998 Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization Invest Ophthalmol Vis Sci 39 7 1097 1106
133. A Moghaddam HT Zhang TP Fan 1995 Thymidine phosphorylase is angiogenic and promotes tumor growth Proc Natl Acad Sci USA 92 4 998 1002 10.1073/pnas.92.4.998
134. AL Harris H Zhang A Moghaddam 1996 Breast cancer angiogenesis - new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting Breast Cancer Res Treat 38 1 97 108 10.1007/BF01803788
135. J Slavin 1995 Fibroblast growth factors: at the heart of angiogenesis Cell Biol Int 19 5 431 444 10.1006/cbir.1995.1087
136. EK Rofstad EF Halsor 2000 Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts Cancer Res 60 17 4932 4938
137. M Stubbs PM McSheehy JR Griffiths 2000 Causes and consequences of tumour acidity and implications for treatment Mol Med Today 6 1 15 19 10.1016/S1357-4310(99)01615-9
138. N Raghunand RA Gatenby RJ Gillies 2003 Microenvironmental and cellular consequences of altered blood flow in tumours Br J Radiol 76 Suppl 1 S11 S22
139. R Bartrons J Caro 2007 Hypoxia, glucose metabolism and the Warburg's effect J Bioenerg Biomembr 39 3 223 229 10.1007/s10863-007-9080-3
140. RA Gatenby RJ Gillies 2004 Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 11 891 899 10.1038/nrc1478
141. JD Gordan MC Simon 2007 Hypoxia-inducible factors: central regulators of the tumor phenotype Curr Opin Genet Dev 17 1 71 77 10.1016/j.gde.2006.12.006
142. GL Semenza 2007 HIF-1 mediates the Warburg effect in clear cell renal carcinoma J Bioenerg Biomembr 39 3 231 234 10.1007/s10863-007-9081-2
143. OK Schlappack A Zimmermann RP Hill 1991 Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells Br J Cancer 64 4 663 670
144. EK Rofstad B Mathiesen K Kindem 2006 Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice Cancer Res 66 13 6699 6707 10.1158/0008-5472.CAN-06-0983
145. RE Moellering KC Black C Krishnamurty 2008 Acid treatment of melanoma cells selects for invasive phenotypes Clin Exp Metastasis 25 4 411 425
146. T Kalliomaki RP Hill 2004 Effects of tumour acidification with glucose + MIBG on the spontaneous metastatic potential of two murine cell lines Br J Cancer 90 9 1842 1849
147. S Walenta S Snyder ZA Haroon 2001 Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model Int J Radiat Oncol Biol Phys 51 3 840 848 10.1016/S0360-3016(01)01700-X
148. D Fukumura L Xu Y Chen 2001 Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo Cancer Res 61 16 6020 6024
149. JR Less MC Posner Y Boucher 1992 Interstitial hypertension in human breast and colorectal tumors Cancer Res 52 6371 6374
150. SD Nathanson L Nelson 1994 Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma Ann Surg Oncol 1 333 338
151. BD Curti WJ Urba WG Alvord 1993 Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment Cancer Res 53 2204 2207
152. Y Boucher JM Kirkwood D Opacic 1991 Interstitial hypertension in superficial metastatic melanomas in humans Cancer Res 51 6691 6694
153. R Gutmann M Leunig J Feyh 1992 Interstitial hypertension in head and neck tumors in patients: correlation with tumor size Cancer Res 52 1993 1995
154. M Milosevic A Fyles D Hedley 2001 Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements Cancer Res 61 17 6400 6405
155. HD Roh S Kalnicki R Buchsbaum 1991 Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response Cancer Res 51 6695 6698
156. TP Padera A Kadambi E di Tomaso 2002 Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 5574 1883 1886 10.1126/science.1071420
157. AJ Leu DA Berk A Lymboussaki 2000 Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation Cancer Res 60 4324 4327
158. SJ Lunt TM Kalliomaki A Brown 2008 Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours BMC Cancer 8 1 2 10.1186/1471-2407-8-2
159. RK Jain RT Tong LL Munn 2007 Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model Cancer Res 67 6 2729 2735 10.1158/0008-5472.CAN-06-4102
160. CH Heldin K Rubin K Pietras 2004 High interstitial fluid pressure - an obstacle in cancer therapy Nat Rev Cancer 4 10 806 813 10.1038/nrc1456
161. A Oldberg S Kalamajski AV Salnikov 2007 Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma Proc Natl Acad Sci USA 104 35 13966 13971 10.1073/pnas.0702014104
162. H Wiig K Rubin RK Reed 2003 New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequences Acta Anaesthesiol Scand 47 111 121 10.1034/j.1399-6576.2003.00050.x
163. K Pietras T Sjoblom K Rubin 2003 PDGF receptors as cancer drug targets Cancer Cell 3 5 439 443 10.1016/S1535-6108(03)00089-8
164. K Pietras K Rubin T Sjoblom 2002 Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy Cancer Res 62 19 5476 5484
165. K Pietras A Ostman M Sjoquist 2001 Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors Cancer Res 61 7 2929 2934
166. JD Mocanu KW Yip NM Alajez 2007 Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy Mol Ther 15 5 921 929
167. G Vlahovic AM Ponce Z Rabbani 2007 Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts Br J Cancer 97 6 735 740 10.1038/sj.bjc.6603941
168. CG Lee M Heijn E di Tomaso 2000 Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 19 5565 5570
169. F Curnis A Sacchi A Corti 2002 Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration J Clin Invest 110 4 475 482
170. K Pietras M Stumm M Hubert 2003 STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake Clin Cancer Res 9 10 pt 1 3779 3787
171. EK Rofstad SH Tunheim B Mathiesen 2002 Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts Cancer Res 62 3 661 664
172. AV Salnikov NE Heldin LB Stuhr 2006 Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinoma Int J Cancer 119 12 2795 2802 10.1002/ijc.22217
173. Y Boucher I Lee RK Jain 1995 Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors Microvasc Res 50 2 175 182 10.1006/mvre.1995.1051
174. I Tufto H Lyng EK Rofstad 1996 Interstitial fluid pressure, perfusion rate and oxygen tension in human melanoma xenografts Br J Cancer 74 Suppl 27 S252 S255
175. SD Nathanson 2003 Insights into the mechanisms of lymph node metastasis Cancer 98 2 413 423 10.1002/cncr.11464
176. L Baxter R Jain 1989 Transport of fluid and macromolecules in tumors I. Role of interstitial pressure and convection Microvasc Res 37 77 104 10.1016/0026-2862(89)90074-5
177. Y Boucher LT Baxter RK Jain 1990 Interstitial pressure gradients in tissue isolated and subcutaneous tissues: implications for therapy Cancer Res 50 4478 4484
178. RP Hill R Perris 2007 "Destemming" cancer stem cells J Natl Cancer Inst 99 19 1435 1440 10.1093/jnci/djm136
179. T Craig MLG Jordan M Noble 2006 Cancer stem cells N Engl J Med 355 12 1253 1261 10.1056/NEJMra061808
180. MF Clarke JE Dick PB Dirks 2006 Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 19 9339 9344
181. BC Barnhart MC Simon 2007 Metastasis and stem cell pathways Cancer Metastasis Rev 26 2 261 271 10.1007/s10555-007-9053-3
182. B Keith MC Simon 2007 Hypoxia-inducible factors, stem cells, and cancer Cell 129 3 465 472 10.1016/j.cell.2007.04.019
183. A Giatromanolaki MI Koukourakis E Sivridis 2001 Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival Br J Cancer 85 6 881 890 10.1054/bjoc.2001.2018
184. SF Schoppmann A Fenzl M Schindl 2006 Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer Breast Cancer Res Treat 99 2 135 141 10.1007/s10549-006-9190-3
185. K Okada M Osaki K Araki 2005 Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas Anticancer Res 25 4 3003 3009
186. M Ueda YC Hung Y Terai 2005 Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas Clin Cancer Res 11 9 3225 3232 10.1158/1078-0432.CCR-04-1148
187. YJ Le PM Corry 1999 Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway Mol Cell Biochem 202 1-2 1 8 10.1023/A:1007059806016
188. A Giatromanolaki MI Koukourakis GP Stathopoulos 2000 Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer Oncol Res 12 1 33 41
189. R Bos PJ van Diest JS de Jong 2005 Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer Histopathology 46 1 31 36 10.1111/j.1365-2559.2005.02045. x
190. PL Marjon EV Bobrovnikova-Marjon SF Abcouwer 2004 Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress Mol Cancer 3 1 4 10.1186/1476-4598-3-4
191. EV Bobrovnikova-Marjon PL Marjon O Barbash 2004 Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1 Cancer Res 64 14 4858 4869 10.1158/0008-5472.CAN-04-0682
192. EK Rofstad B Mathiesen K Henriksen 2005 The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products Cancer Res 65 6 2387 2396 10.1158/0008-5472.CAN-04-3039
193. SK Kassim EM El-Salahy ST Fayed 2004 Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients Clin Biochem 37 5 363 369 10.1016/j.clinbiochem.2004.01.014
194. L Griffiths GU Dachs R Bicknell 1997 The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo Cancer Res 57 4 570 572
195. A Maity D Solomon 2000 Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia Exp Cell Res 255 2 250 257 10.1006/excr.1999.4804
196. S Memarzadeh KR Kozak L Chang 2002 Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer Proc Natl Acad Sci USA 99 16 10647 10652 10.1073/pnas.152127499
197. SY Yoon YJ Lee JH Seo 2006 uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line Cell Res 16 1 75 81 10.1038/sj.cr.7310010
198. UM Munoz-Najar KM Neurath F Vumbaca 2006 Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation Oncogene 25 16 2379 2392 10.1038/sj.onc.1209273
199. S Lukacova AA Khalil J Overgaard 2005 Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum Int J Radiat Biol 81 12 937 944 10.1080/09553000600567616
200. HM Said A Katzer M Flentje 2005 Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells Radiother Oncol 76 2 200 205 10.1016/j.radonc.2005.06.023
201. MC Smith KE Luker JR Garbow 2004 CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 23 8604 8612 10.1158/0008-5472.CAN- 04-1844
202. H Shim SK Lau S Devi 2006 Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha Biochem Biophys Res Commun 346 1 252 258 10.1016/j.bbrc.2006.05.110
203. P Staller J Sulitkova J Lisztwan 2003 Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 425 6955 307 311 10.1038/nature01874
204. C Baykal A Ayhan A Al 2003 Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas Gynecol Oncol 88 2 123 129 10.1016/S0090-8258(02)00073-2
205. A Ayhan D Ertunc EC Tok 2005 Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance Int J Gynecol Cancer 15 4 618 623 10.1111/j.1525-1438.2005.00117.x
206. T Ide Y Kitajima A Miyoshi 2006 Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway Int J Cancer 119 12 2750 2759 10.1002/ijc.22178
207. D Nie S Krishnamoorthy R Jin 2006 Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells J Biol Chem 281 27 18601 18609 10.1074/jbc.M601887200
208. LM Postovit DE Abbott SL Payne 2008 Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration J Cell Biochem 103 5 1369 1378
209. Zhang L, Hill RP (2004) Hypoxia enhances metastatic efficiency by up regulating mdm2 in KHT cells and increasing resistance to apoptosis. Cancer Res 64(12):4180-4189
210. JI Bardos NM Chau M Ashcroft 2004 Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression Mol Cell Biol 24 7 2905 2914 10.1128/MCB.24.7.2905-2914.2004
211. G Storci P Sansone D Trere 2008 The basal-like breast carcinoma phenotype is regulated by SLUG gene expression J Pathol 214 1 25 37 10.1002/path.2254
212. S Tsutsumi T Yanagawa T Shimura 2004 Autocrine motility factor signaling enhances pancreatic cancer metastasis Clin Cancer Res 10 22 7775 7784 10.1158/1078-0432.CCR-04-1015
213. DY Yoon P Buchler ST Saarikoski 2001 Identification of genes differentially induced by hypoxia in pancreatic cancer cells Biochem Biophys Res Commun 288 4 882 886 10.1006/bbrc.2001.5867
214. H Niizeki M Kobayashi I Horiuchi 2002 Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells Br J Cancer 86 12 1914 1919 10.1038/sj.bjc.6600331
215. T Funasaka T Yanagawa V Hogan 2005 Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia FASEB J 19 11 1422 1430 10.1096/fj.05-3699com